Biogen’s stock climbs as first-quarter profit tops estimates, Alzheimer’s drug uptake improves

Biogen shares gained ground before market open Wednesday, after the company reported first-quarter profit that beat analysts’ expectations amid improving uptake of its Alzheimer’s treatment.

Source: MarketWatch

Continue reading...